FDA clears K2M's tifix Cayman spinal implants
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for K2M's Cayman buttress plate system and Cayman thoracolumbar plate system. The implants are designed for use in the thoracolumbar, lumbar and sacral areas of the spine in trauma and tumour patients. The spinal implants use the Leesburg, Virginia firm's tifix locking technology, whereby each screw head locks to the plate upon insertion, requiring no other fixation. Additionally, the multidirectional screws allow up to 45 degrees of angulation and lagging of the implant to the bone.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.